Literature DB >> 18790646

RCAI-17, 22, 24-26, 29, 31, 34-36, 38-40, and 88, the analogs of KRN7000 with a sulfonamide linkage: their synthesis and bioactivity for mouse natural killer T cells to produce Th2-biased cytokines.

Takuya Tashiro1, Naomi Hongo, Ryusuke Nakagawa, Ken-Ichiro Seino, Hiroshi Watarai, Yasuyuki Ishii, Masaru Taniguchi, Kenji Mori.   

Abstract

RCAI-17, 22, 24-26, 29, 31, 34-36, 38-40, and 88, the analogs of KRN7000 with a sulfonamide linkage instead of an amide bond, were synthesized to examine their bioactivity for mouse natural killer (NK) T cells. RCAI-17, 22, 24-26, 29, 31, 34-36, and 88 are the aromatic sulfonamide analogs, while RCAI-39 and 40 are the aliphatic ones. RCAI-38 is a C-galactoside analog of RCAI-26, which is the p-toluenesulfonamide analog of KRN7000. According to their bioassay, these sulfonamide analogs were shown to be the stimulants of mouse NKT cells to induce the production of Th2-biased cytokines in vitro, while RCAI-38 did not induce any cytokine production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18790646     DOI: 10.1016/j.bmc.2008.08.060

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Synthesis and biological activities of C-glycosides of KRN 7000 with novel ceramide residues.

Authors:  Ahmad S Altiti; Xiaojing Ma; Lixing Zhang; Yi Ban; Richard W Franck; David R Mootoo
Journal:  Carbohydr Res       Date:  2017-03-06       Impact factor: 2.104

2.  The Crotylation Way to Glycosphingolipids: Synthesis of Analogues of KRN7000.

Authors:  Ahmad S Altiti; Stewart Bachan; David R Mootoo
Journal:  Org Lett       Date:  2016-08-25       Impact factor: 6.005

Review 3.  Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.

Authors:  Manjunatha M Venkataswamy; Steven A Porcelli
Journal:  Semin Immunol       Date:  2009-11-27       Impact factor: 11.130

Review 4.  Glycolipid activators of invariant NKT cells as vaccine adjuvants.

Authors:  Shalu Sharma Kharkwal; Pooja Arora; Steven A Porcelli
Journal:  Immunogenetics       Date:  2016-07-05       Impact factor: 2.846

Review 5.  Stimulation of natural killer T cells by glycolipids.

Authors:  Brian L Anderson; Luc Teyton; Albert Bendelac; Paul B Savage
Journal:  Molecules       Date:  2013-12-16       Impact factor: 4.411

6.  NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity.

Authors:  Regan J Anderson; Benjamin J Compton; Ching-Wen Tang; Astrid Authier-Hall; Colin M Hayman; Gene W Swinerd; Renata Kowalczyk; Paul Harris; Margaret A Brimble; David S Larsen; Olivier Gasser; Robert Weinkove; Ian F Hermans; Gavin F Painter
Journal:  Chem Sci       Date:  2015-06-25       Impact factor: 9.825

Review 7.  Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.

Authors:  Jung-Tung Hung; Jing-Rong Huang; Alice L Yu
Journal:  J Biomed Sci       Date:  2017-03-23       Impact factor: 8.410

8.  A Designed α-GalCer Analog Promotes Considerable Th1 Cytokine Response by Activating the CD1d-iNKT Axis and CD11b-Positive Monocytes/Macrophages.

Authors:  Juan Ma; Peng He; Chuanfang Zhao; Quanzhong Ren; Zheng Dong; Jiahuang Qiu; Yang Jing; Sijin Liu; Yuguo Du
Journal:  Adv Sci (Weinh)       Date:  2020-06-08       Impact factor: 16.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.